5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepin-7-ol has been researched along with Alcohol Abuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eder, DN | 1 |
1 review(s) available for 5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepin-7-ol and Alcohol Abuse
Article | Year |
---|---|
CEE-03-310 CeNeS pharmaceuticals.
Topics: Alcoholism; Animals; Benzazepines; Benzofurans; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dopamine Antagonists; Drugs, Investigational; Humans; Lethal Dose 50; Randomized Controlled Trials as Topic; Receptors, Dopamine D1; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship; Treatment Outcome | 2002 |